Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-08 Purchase(A) |
2023-02-17 6:40 pm |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
27,000 | $1.8929 | $51,108 | 435,514 (Indirect) |
View |
| 2022-12-08 Purchase |
2022-12-12 4:30 pm |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
1,238 | $1.61 | $1,993 | 2,738 (Direct) |
View |
| 2022-12-08 Purchase |
2022-12-12 4:25 pm |
Candel Therapeutics Inc. | CADL | PAPA JOSEPH C Director |
38,032 | $1.921 | $73,059 | 38,032 (Direct) |
View |
| 2022-12-08 Purchase |
2022-12-12 4:25 pm |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
27,000 | $1.8929 | $51,108 | 152,000 (Direct) |
View |
| 2022-12-08 Purchase |
2022-12-12 4:25 pm |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
15,985 | $1.878 | $30,020 | 40,985 (Direct) |
View |
| 2022-12-08 Purchase |
2022-12-12 4:25 pm |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
13,358 | $1.8761 | $25,061 | 13,358 (Direct) |
View |
| 2022-12-08 Purchase |
2022-12-12 4:25 pm |
Candel Therapeutics Inc. | CADL | Amello Jason Chief Financial Officer |
5,568 | $1.7964 | $10,002 | 5,568 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-04-28 Option Award |
2023-05-02 5:10 pm |
N/A 2033-04-28 |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
180,000 | $0 | 180,000 (Direct) |
View |
| 2023-04-28 Option Award |
2023-05-02 5:05 pm |
N/A 2033-04-28 |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2023-04-28 Option Award |
2023-05-02 5:00 pm |
N/A 2033-04-28 |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
45,000 | $0 | 45,000 (Direct) |
View |
| 2023-04-28 Option Award |
2023-05-02 4:50 pm |
N/A 2033-04-28 |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2023-04-28 Option Award |
2023-05-02 4:45 pm |
N/A 2033-04-28 |
Candel Therapeutics Inc. | CADL | Amello Jason Chief Financial Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-11-28 Option Award |
2022-11-30 6:31 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Amello Jason Chief Financial Officer |
90,877 | $0 | 90,877 (Direct) |
View |
| 2022-11-28 Option Award |
2022-11-30 6:30 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
195,906 | $0 | 220,906 (Direct) |
View |
| 2022-11-28 Option Award |
2022-11-30 6:30 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
90,877 | $0 | 92,377 (Direct) |
View |
| 2022-11-28 Option Award |
2022-11-30 6:29 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
58,479 | $0 | 58,479 (Direct) |
View |
| 2022-11-28 Option Award |
2022-11-30 6:26 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu See Remarks |
73,684 | $0 | 73,684 (Direct) |
View |
| 2022-10-13 Option Award |
2022-10-17 4:45 pm |
N/A 2032-10-13 |
Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2022-10-13 Option Award |
2022-10-17 4:45 pm |
N/A 2032-10-13 |
Candel Therapeutics Inc. | CADL | Nguyen Diem Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2022-10-13 Option Award |
2022-10-17 4:42 pm |
N/A 2032-10-13 |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2022-10-13 Option Award |
2022-10-17 4:36 pm |
N/A 2032-10-13 |
Candel Therapeutics Inc. | CADL | Benz Edward J. JR Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2022-10-13 Option Award |
2022-10-17 4:36 pm |
N/A 2032-10-13 |
Candel Therapeutics Inc. | CADL | Manning Paul B Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2022-09-21 Option Award |
2022-09-23 4:15 pm |
N/A 2032-09-21 |
Candel Therapeutics Inc. | CADL | Amello Jason Chief Financial Officer |
230,000 | $0 | 230,000 (Direct) |
View |
| 2022-09-12 Option Award |
2022-09-14 5:05 pm |
N/A 2032-09-12 |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-08-08 Option Award |
2022-08-10 08:05 am |
N/A 2032-08-08 |
Candel Therapeutics Inc. | CADL | Gaeta Renee Director |
28,480 | $0 | 28,480 (Direct) |
View |
| 2022-08-08 Option Award |
2022-08-10 08:05 am |
N/A 2032-08-08 |
Candel Therapeutics Inc. | CADL | Nabel Gary J. Director |
28,480 | $0 | 28,480 (Direct) |
View |
| 2022-08-08 Option Award |
2022-08-10 08:05 am |
N/A 2032-08-08 |
Candel Therapeutics Inc. | CADL | PAPA JOSEPH C Director |
28,480 | $0 | 28,480 (Direct) |
View |
| 2022-05-06 Exercise |
2022-05-10 6:07 pm |
N/A 2028-08-17 |
Candel Therapeutics Inc. | CADL | Aguilar Laura K. 10% Owner |
171,335 | $0 | 3,046,940 (Direct) |
View |
| 2022-05-06 Exercise |
2022-05-10 6:07 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Aguilar Laura K. 10% Owner |
171,335 | $1.46 | 3,046,940 (Direct) |
View |
| 2022-05-06 Tax Withholding |
2022-05-10 6:07 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Aguilar Laura K. 10% Owner |
68,534 | $3.65 | 3,046,940 (Direct) |
View |
| 2022-05-06 Exercise |
2022-05-10 6:04 pm |
N/A 2028-08-17 |
Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Director 10% Owner |
135,183 | $0 | 3,202,430 (Direct) |
View |
| 2022-05-06 Exercise |
2022-05-10 6:04 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Director 10% Owner |
135,183 | $1.46 | 3,202,430 (Direct) |
View |
| 2022-05-06 Tax Withholding |
2022-05-10 6:04 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Director 10% Owner |
54,074 | $3.65 | 3,202,430 (Direct) |
View |
| 2022-04-14 Option Award |
2022-04-15 5:05 pm |
N/A 2032-04-14 |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu See Remarks |
120,000 | $0 | 120,000 (Direct) |
View |
| 2022-04-11 Option Award |
2022-04-12 5:15 pm |
N/A 2032-04-11 |
Candel Therapeutics Inc. | CADL | Stewart Susan B. Chief Regulatory Officer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-01 6:40 pm |
N/A 2032-02-28 |
Candel Therapeutics Inc. | CADL | Canepa John J Chief Financial Officer |
110,000 | $0 | 110,000 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-01 6:35 pm |
N/A 2032-02-28 |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
330,000 | $0 | 330,000 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-01 6:34 pm |
N/A 2032-02-28 |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
110,000 | $0 | 110,000 (Direct) |
View |